Schechter Investment Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$9.16M Sell
34,524
-10,575
-23% -$2.61M 0.75% 23
2024
Q4
$10.5M Sell
45,099
-608
-1% -$140K 0.8% 22
2024
Q3
$10.1M Buy
45,707
+261
+0.6% +$54K 0.74% 27
2024
Q2
$8.93M Sell
45,446
-1,614
-3% -$333K 0.67% 32
2024
Q1
$10.1M Sell
47,060
-58
-0.1% -$12.2K 0.76% 29
2023
Q4
$9.92M Sell
47,118
-351
-0.7% -$74.9K 0.86% 25
2023
Q3
$9.5M Buy
47,469
+274
+0.6% +$54.5K 0.92% 22
2023
Q2
$8.74M Sell
47,195
-690
-1% -$128K 0.79% 24
2023
Q1
$9.17M Buy
47,885
+4,621
+11% +$836K 0.85% 20
2022
Q4
$7.28M Sell
43,264
-1,011
-2% -$176K 0.66% 16
2022
Q3
$7.84M Sell
44,275
-30
-0.1% -$5.93K 0.77% 14
2022
Q2
$9.07M Sell
44,305
-810
-2% -$172K 0.88% 11
2022
Q1
$10.7M Buy
45,115
+207
+0.5% +$48.6K 1% 9
2021
Q4
$10.3M Buy
+44,908
New +$9.88M 0.93% 12

Other funds holding CME

Schechter Investment Advisors's CME Position: Q1 2025 in Review

Schechter Investment Advisors reduced its CME Group (CME) stake by 23% in Q1 2025, selling an estimated $2.61M and leaving 34,524 shares worth $9.16M. The position accounts for 0.75% of the portfolio, ranked #23.

Schechter Investment Advisors first reported a position in CME in Q4 2021 and has held it in 14 quarters since. The position peaked at $10.7M in Q1 2022. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • Schechter Investment Advisors held 34,524 shares of CME Group worth $9.16M as of Q1 2025.
  • Schechter Investment Advisors sold 10,575 CME Group shares in Q1 2025, an estimated $2.61M.
  • CME Group made up 0.75% of Schechter Investment Advisors's portfolio in Q1 2025, its #23 holding.
  • Schechter Investment Advisors first reported a position in CME Group in Q4 2021 and has held it in 14 quarters since.
  • Schechter Investment Advisors's CME Group position peaked at $10.7M in Q1 2022.
  • 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.